Persistent hypoaldosteronism post-adrenalectomy for primary aldosteronism - a role for pre-operative spironolactone?

Area of Science:

• Endocrinology
• Cardiology
• Nephrology

Background:

• Primary aldosteronism affects up to 10% of hypertensive patients, increasing risks of atrial fibrillation, stroke, and myocardial infarction.
• Underdiagnosis is common, leading to delayed treatment and potential complications.
• Adrenalectomy is a treatment for primary aldosteronism, but can lead to hypoaldosteronism.

Purpose of the Study:

• To highlight the complication of persistent post-operative hypoaldosteronism after adrenalectomy for primary aldosteronism.
• To discuss the management of severe hyponatraemia and hyperkalaemia in this context.
• To explore the potential role of pre-operative mineralocorticoid receptor antagonists in preventing this complication.

Main Methods:

• Case report detailing a patient with delayed diagnosis of primary aldosteronism and subsequent persistent hypoaldosteronism.
• Review of literature on hypoaldosteronism following adrenalectomy.
• Discussion of risk factors and potential preventative strategies.

Main Results:

• The case experienced protracted, persistent hypoaldosteronism with severe hyponatraemia and hyperkalaemia post-adrenalectomy.
• Long-term mineralocorticoid replacement was necessary.
• Risk factors for hypoaldosteronism include age >50, hypertension duration >10 years, renal impairment, and large adenoma size.

Conclusions:

• Hypoaldosteronism is an uncommon but potentially persistent complication of adrenalectomy for primary aldosteronism.
• Routine electrolyte monitoring post-adrenalectomy is crucial.
• The efficacy of pre-operative mineralocorticoid receptor antagonists in preventing post-operative hypoaldosteronism requires further investigation.